Argenx Se (ARGX) Profit After Tax (2016 - 2026)

Argenx Se (ARGX) posted quarterly Profit After Tax of $362.0 million for Q2 2026, up 101.22% year-on-year from $179.9 million in Q2 2025, and down 27.31% on a QoQ basis from $498.0 million in Q1 2026.

Argenx Se (ARGX) Profit After Tax (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Profit After Tax for 11 consecutive years, with $362.0 million the latest figure, recorded in Q2 2026.

  • Quarterly Profit After Tax rose 101.22% year-over-year to $362.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (up 1740.86% YoY) and the FY2025 annual result came in at $1.3 billion, up 55.1% from the prior year.
  • Profit After Tax fell to $362.0 million in Q2 2026 per ARGX's latest filing, from $498.0 million in the prior quarter.
  • Over the last five years, Profit After Tax for ARGX reached as high as $498.0 million in Q1 2026 and fell as low as -$651.9 million in Q2 2022.
  • A 5-year average of $67.9 million and a median of $80.7 million in 2023 frame the typical range for Profit After Tax.
  • The largest YoY upside for Profit After Tax was 434.22% in 2022 against a maximum downside of 2967.68% in 2022.
  • Year by year, Profit After Tax stood at $41.2 million in 2022, then slumped by 156.22% to -$23.2 million in 2023, then slumped by 2504.39% to -$603.8 million in 2024, then soared by 166.79% to $403.3 million in 2025, then dropped by 10.24% to $362.0 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered $362.0 million, $498.0 million, and $403.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.84 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 205.99 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 362.00 Mn
Mar 31, 2026 498.00 Mn
Dec 31, 2025 403.29 Mn
Sep 30, 2025 386.05 Mn
Jun 30, 2025 179.90 Mn
Mar 31, 2025 235.36 Mn
Dec 31, 2024 -603.80 Mn
Sep 30, 2024 88.02 Mn
Jun 30, 2024 -59.07 Mn
Mar 31, 2024 -108.90 Mn
Dec 31, 2023 -23.18 Mn
Sep 30, 2023 -83.28 Mn
Jun 30, 2023 73.35 Mn
Mar 31, 2023 28.87 Mn
Dec 31, 2022 41.24 Mn
Sep 30, 2022 241.02 Mn
Jun 30, 2022 -651.94 Mn
Mar 31, 2022 216.00 Mn
Dec 31, 2021 244.88 Mn
Sep 30, 2021 -230.87 Mn